549 related articles for article (PubMed ID: 23051748)
1. Structure of the agonist-bound neurotensin receptor.
White JF; Noinaj N; Shibata Y; Love J; Kloss B; Xu F; Gvozdenovic-Jeremic J; Shah P; Shiloach J; Tate CG; Grisshammer R
Nature; 2012 Oct; 490(7421):508-13. PubMed ID: 23051748
[TBL] [Abstract][Full Text] [Related]
2. In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist.
Lückmann M; Holst B; Schwartz TW; Frimurer TM
Mol Inform; 2016 Jan; 35(1):19-24. PubMed ID: 27491650
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
[TBL] [Abstract][Full Text] [Related]
4. Effect of thermostable mutations on the neurotensin receptor 1 (NTSR
Nagarajan S; Alkayed NJ; Kaul S; Barnes AP
J Biomol Struct Dyn; 2020 Feb; 38(2):340-353. PubMed ID: 30706767
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator.
Krumm BE; DiBerto JF; Olsen RHJ; Kang HJ; Slocum ST; Zhang S; Strachan RT; Huang XP; Slosky LM; Pinkerton AB; Barak LS; Caron MG; Kenakin T; Fay JF; Roth BL
Biochemistry; 2023 Apr; 62(7):1233-1248. PubMed ID: 36917754
[TBL] [Abstract][Full Text] [Related]
6. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
[TBL] [Abstract][Full Text] [Related]
7. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
[TBL] [Abstract][Full Text] [Related]
8. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1.
Barroso S; Richard F; Nicolas-Ethève D; Reversat JL; Bernassau JM; Kitabgi P; Labbé-Jullié C
J Biol Chem; 2000 Jan; 275(1):328-36. PubMed ID: 10617622
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
[TBL] [Abstract][Full Text] [Related]
10. Structural dynamics and thermostabilization of neurotensin receptor 1.
Lee S; Bhattacharya S; Tate CG; Grisshammer R; Vaidehi N
J Phys Chem B; 2015 Apr; 119(15):4917-28. PubMed ID: 25807267
[TBL] [Abstract][Full Text] [Related]
11. Structure and dynamics of a constitutively active neurotensin receptor.
Krumm BE; Lee S; Bhattacharya S; Botos I; White CF; Du H; Vaidehi N; Grisshammer R
Sci Rep; 2016 Dec; 6():38564. PubMed ID: 27924846
[TBL] [Abstract][Full Text] [Related]
12. Direct analysis of a GPCR-agonist interaction by surface plasmon resonance.
Harding PJ; Hadingham TC; McDonnell JM; Watts A
Eur Biophys J; 2006 Oct; 35(8):709-12. PubMed ID: 16708210
[TBL] [Abstract][Full Text] [Related]
13. Activation Dynamics of the Neurotensin G Protein-Coupled Receptor 1.
Cong X; Fiorucci S; Golebiowski J
J Chem Theory Comput; 2018 Aug; 14(8):4467-4473. PubMed ID: 29965755
[TBL] [Abstract][Full Text] [Related]
14. Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experiments.
Sparr C; Purkayastha N; Yoshinari T; Seebach D; Maschauer S; Prante O; Hübner H; Gmeiner P; Kolesinska B; Cescato R; Waser B; Reubi JC
Chem Biodivers; 2013 Dec; 10(12):2101-21. PubMed ID: 24327436
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
[TBL] [Abstract][Full Text] [Related]
16. Optimization and
Bumbak F; Keen AC; Gunn NJ; Gooley PR; Bathgate RAD; Scott DJ
Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1372-1383. PubMed ID: 29596791
[TBL] [Abstract][Full Text] [Related]
17. G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro.
Inagaki S; Ghirlando R; Vishnivetskiy SA; Homan KT; White JF; Tesmer JJ; Gurevich VV; Grisshammer R
Biochemistry; 2015 Jul; 54(28):4320-9. PubMed ID: 26120872
[TBL] [Abstract][Full Text] [Related]
18. Probing the environment of neurotensin whilst bound to the neurotensin receptor by solid state NMR.
Williamson PT; Bains S; Chung C; Cooke R; Watts A
FEBS Lett; 2002 May; 518(1-3):111-5. PubMed ID: 11997028
[TBL] [Abstract][Full Text] [Related]
19. Conformational transitions of a neurotensin receptor 1-G
Kato HE; Zhang Y; Hu H; Suomivuori CM; Kadji FMN; Aoki J; Krishna Kumar K; Fonseca R; Hilger D; Huang W; Latorraca NR; Inoue A; Dror RO; Kobilka BK; Skiniotis G
Nature; 2019 Aug; 572(7767):80-85. PubMed ID: 31243364
[TBL] [Abstract][Full Text] [Related]
20. Function and mechanism of neurotensin (NTS) and its receptor 1 (NTSR1) in occurrence and development of tumors.
Hu HR; Dong Z; Yi L; He XY; Zhang YL; Liu YL; Cui HJ
Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(13):2524-36. PubMed ID: 26697673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
